Abstract Proton Pump Inhibitors (PPI) are very effective in inhibiting acid secretion and are
extensively used in many acid related diseases. They are also often used in patients with …

Since the historical rediscovery of gastric spiral Helicobacter pylori in the gastric mucosa of
patients with chronic gastritis by Warren and Marshall in 1983, peptic ulcer disease has …

Background The frequency of gastrointestinal ulcerations is higher in cirrhotic patients than
in the normal population. It has been shown that pioglitazone exhibits gastroprotective …

AIM: To systematically review the data on distinctive aspects of peptic ulcer disease (PUD),
Dieulafoy's lesion (DL), and Mallory-Weiss syndrome (MWS) in patients with advanced …

Background: Non-Helicobacter pylori, non-NSAID ulcer is relatively common in Western
countries. Whether it is a significant problem in the Orient is unclear. The aim of this study …

The discovery of Helicobacter hepaticus as a causal agent of hepatitis and hepatocellular
carcinoma (HCC) in mice has stimulated interest in looking for Helicobacter species in …

Gastroduodenal ulcers and gastroduodenal erosions are particularly frequent in cirrhotic
patients, but their precise cause is unclear. The aim of this study was to identify pathogenic …

Background/Aims: The role of H. pylori in the pathogenesis of ulcer disease in cirrhotic
patients is poorly defined. Therefore, we sought to investigate the prevalence of H. pylori …

Background The role of Helicobacter pylori (H. pylori) in the pathogenesis of portal
hypertensive gastropathy (PHG) in cirrhotic patients is poorly defined. The aim of this study …

Background Peptic ulcer disease is highly prevalent in cirrhosis, and ulcer complications are
a major cause of morbidity in these patients. Helicobacter pylori infection is considered the …